Despite the fact that dominant-negative mutant transcripts of KAP have been identified in HCC and glioblastoma, these findings are not sufficient to explain why KAP overexpression promotes tumor cell growth. The gene discussed is CDKN3; the disease is hepatocellular carcinoma.